Suppressor of cytokine signaling-1 reduces high glucose-induced TGF-β1 and fibronectin synthesis in human mesangial cells

FEBS Letters

Volumn 582, Issue 23-24, 2008, Pages 3484-3488

  Shi, Yonghong ^a   Zhang, Yanling ^a   Wang, Chen ^a   Du, Chunyang ^a   Zhao, Song ^a   Qi, Zhao ^a   Zhang, Qingxian ^a   Duan, Huijun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Glomerular mesangial cell; High glucose; JAK2 STAT; SOCS 1

Indexed keywords

FIBRONECTIN; GLUCOSE; JANUS KINASE 2; PROTEIN C FOS; PROTEIN C JUN; STAT1 PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSFORMING GROWTH FACTOR BETA1; TYROSINE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

CELLS, CULTURED; FIBRONECTINS; GLUCOSE; HUMANS; JANUS KINASE 2; MESANGIAL CELLS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSFORMING GROWTH FACTOR BETA1; TYROSINE;

EID: 53049110853     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.09.014     Document Type: Article

References (21)

1. Kim S.I., Han D.C., and Lee H.B. Lovastatin inhibits transforming growth factor-β1 expression in diabetic rat glomeruli and cultured rat mesangial cells. J. Am. Soc. Nephrol. 11 (2000) 80-87
2. Oh J.H., Ha H., Yu M.R., and Lee H.B. Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis. Kidney Int. 54 (1998) 1872-1878
3. Marrero M.B., Banes-Berceli A.K., Stern D.M., and Eaton D.C. Role of the JAK/STAT signaling pathway in diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 290 (2006) F762-F768
4. Wang X., Shaw S., Amiri F., Eaton D.C., and Marrero M.B. Inhibition of the Jak/STAT signaling pathway prevents the high glucose-induced increase in tgf-beta and fibronectin synthesis in mesangial cells. Diabetes 51 (2002) 3505-3509
5. Amiri F., Shaw S., Wang X., Tang J., Waller J.L., Eaton D.C., and Marrero M.B. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney Int. 61 (2002) 1605-1616
6. Darnell Jr. J.E. STATs and gene regulation. Science 277 (1997) 1630-1635
7. Shuai K., and Liu B. Regulation of the JAK-STAT signalling in the immune system. Nat. Rev. Immunol. 3 (2003) 900-911
8. Starr R., et al. A family of cytokine-inducible inhibitors of signalling. Nature 387 (1997) 917-921
9. Kubo M., Hasana T., and Yoshimura A. Suppressors of cytokine signaling and immunity. Nat. Immunol. 4 (2003) 1169-1176
10. Endo T.A., et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387 (1997) 921-924
11. Naka T., et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 387 (1997) 924-929
12. Yasukawa H., et al. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18 (1999) 1309-1320
13. Hernandez-Vargas P., et al. Suppressors of cytokine signaling regulate angiotensin II-activated Janus kinase-signal transducers and activators of transcription pathway in renal cells. J. Am. Soc. Nephrol. 16 (2005) 1673-1683
14. Leonard M.O., et al. 15-EPO-16 (para-fluorophenoxy)-lipoxin A4-metyl ester, a synthetic analogue of 15-epi-lipoxin A4, is protective in experimental ischemic acute renal failure. J. Am. Soc. Nephrol. 13 (2002) 1657-6962
15. Gomez-Guerrero C., Lopez-Franco O., Sanjuan G., Hernandez-Vargas P., Suzuki Y., Ortiz-Munoz G., Blanco J., and Egido J. Suppressors of cytokine signaling (SOCS) regulate Fc receptor signaling and cell activation during immune renal injury. J. Immunol. 172 (2003) 6969-6977
16. Dong J., Wang Q.X., Zhou C.Y., Ma X.F., and Zhang Y.C. Activation of the STAT1 signalling pathway in lupus nephritis in MRL/lpr mice. Lupus 16 (2007) 101-109
17. Nicholas S.B. Advances in pathogenetic mechanisms of diabetic nephropathy. Cell Mol. Biol. (Noisy-le-grand) 49 (2003) 1319-1325
18. Ziyadeh F.N. Mediators of diabetic renal disease: the case for tgf-beta as the major mediator. J. Am. Soc. Nephrol. 15 Suppl. 1 (2004) S55-S57
19. Ha H., and Lee H.B. Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int. Suppl. 77 (2000) S19-S25
20. Weigert C., Sauer U., Brodbeck K., Pfeiffer A., Haring H.U., and Schleicher E.D. AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-β1 promoter in mesangial cells. J. Am. Soc. Nephrol. 11 (2000) 2007-2016
21. Peng F., Wu D., Gao B., Ingram A., Zhang B., Chorneyko K., McKenzie R., and Krepinsky J.C. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease. Diabetes 57 (2008) 1683-1692